Vertex Pharmaceuticals target price raised to $575 from $550 by TD Cowen
VRTX•TD Cowen raised its target price for Vertex Pharmaceuticals to $575 from $550.
Related News
Klarna expands Mollie partnership to extend payment services across Europe
KLAR•
Hinge Health target price raised to $134 from $105 by Canaccord Genuity
HNGE•
Nasdaq trade halt continues; reason not available at 03:58 a.m.
TJGC•
Fridge hacks and finance attacks flag AI insecurity: Mike Dolan
SPY•
Petrol prices push Swiss inflation higher, raising chances of rate hike
TLT•